8-KThe WireStrategic
Agreement Terminated · Results of Operations
Filed Nov 15, 2021 · 4y ago · Accession 0001193125-21-329000
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- UroGen Pharma Ltd.
- Ticker
- URGN
- CIK
- 1668243
- Form type
- 8-K
- Filing date
- Nov 15, 2021
- Report date
- Nov 11, 2021
- Document
- d243248d8k.htm
- Size
- 235 KB